[Controlled clinical evaluation of a new anti-hemorrhoid drug, using a completely randomized experimental plan].
D010129:4-Aminobenzoic Acid / Q000627:therapeutic use; D000328:Adult; D000368:Aged; D001533:Belladonna Alkaloids / Q000627:therapeutic use*; D002986:Clinical Trials as Topic; D004338:Drug Combinations; D004341:Drug Evaluation; D004928:Escin / Q000627:therapeutic use*; D006484:Hemorrhoids / Q000188:drug therapy*; D006493:Heparin / Q000627:therapeutic use; D006801:Humans; D006854:Hydrocortisone / Q000627:therapeutic use; D008041:Linoleic Acids / Q000627:therapeutic use*; D008042:Linolenic Acids / Q000627:therapeutic use*; D008875:Middle Aged; D009821:Oils; D012503:Saponins / Q000627:therapeutic use*; D013748:Tetracaine / Q000627:therapeutic use*
D001533:Belladonna Alkaloids; D004338:Drug Combinations; D008041:Linoleic Acids; D008042:Linolenic Acids; D009821:Oils; D012503:Saponins; D013748:Tetracaine; D004928:Escin; D006493:Heparin; D010129:4-Aminobenzoic Acid; D006854:Hydrocortisone
Valutazione clinica controllata di un nuovo antiemorroidario secondo un disegno sperimentale completamente randomizzato.